ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

15 links0 made here, not in the record24 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04665206Study to Evaluate VT3989 inPatients With MetastaticSolid TumorsVivace Therapeutics, IncPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 17 · ClinicalTrials.gov record · Version of 2026-11-17Nov 17 · Rule based · Reading set asideNov 18 · Rule based · Reading keptReading keptCONDITIONSMesotheliomaThe registry's MeSH filing›Nov 17 · Rule based · Wider: a narrower term is filedAs of now · Rule based · Main conditionMain conditionMesothelioma, MalignantThe registry's MeSH filing›Nov 17 · Rule based · Finest filed termFinest filed termCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 17 · Rule based · Finest filed termFinest filed termHemangioendothelioma, Epith…The registry's MeSH filing›Nov 17 · Rule based · Finest filed termFinest filed termAdenomaThe registry's MeSH filing›Nov 17 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseNeoplasmsThe registry's MeSH filing›Nov 17 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseNeoplasms, Glandular and Ep…The registry's MeSH filing›Nov 17 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedNeoplasms by Histologic TypeThe registry's MeSH filing›Nov 17 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedNeoplasms, MesothelialThe registry's MeSH filing›Nov 17 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedDRUGSINT010977Entry “VT3989”, read by our name rule›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNivolumabEntry “Nivolumab & Ipilimumab”, read …›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerIpilimumabEntry “Nivolumab & Ipilimumab”, read …›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerOsimertinibIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerPemetrexedEntry “Pemetrexed/Carboplatin”, read …›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCarboplatinEntry “Pemetrexed/Carboplatin”, read …›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT010977

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “VT3989”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2INT010977Claude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5Background · partnerCurrent
Nov 2IpilimumabClaude Opus 5.5Background · partnerCurrent
Nov 2OsimertinibClaude Opus 5.5Background · partnerCurrent
Nov 2PemetrexedClaude Opus 5.5BackgroundCurrent
Nov 2CarboplatinClaude Opus 5.5BackgroundCurrent
Nov 17The record itselfClinicalTrials.gov recordVersion of 2026-11-17Record change
Nov 17The record itselfRule based · nightly checkReading set asideCurrent
Nov 17MesotheliomaRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 17Mesothelioma, MalignantRule based · condition-kind ruleFinest filed termCurrent
Nov 17Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 17Hemangioendothelioma, EpithelioidRule based · condition-kind ruleFinest filed termCurrent
Nov 17AdenomaRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 17NeoplasmsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 17Neoplasms, Glandular and EpithelialRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 17Neoplasms by Histologic TypeRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 17Neoplasms, MesothelialRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 18The record itselfRule based · nightly checkReading keptCurrent
Nov 18INT010977Rule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleBackgroundAgrees
Nov 18IpilimumabRule based · role ruleBackgroundAgrees
Nov 18OsimertinibRule based · role ruleBackgroundAgrees
Nov 18PemetrexedRule based · role ruleBackgroundAgrees
Nov 18CarboplatinRule based · role ruleBackgroundAgrees
As of nowMesotheliomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.

When a study changes after it was read

Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.

Until it is read again, the page shows the last reading and says so.